| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1600-6143.2012.04074.X |
| P8608 | Fatcat ID | release_ryjhez3fwrg4vearugrjppb5qy |
| P932 | PMC publication ID | 4752112 |
| P698 | PubMed publication ID | 22776408 |
| P5875 | ResearchGate publication ID | 229010154 |
| P2093 | author name string | M Song | |
| E A Strobert | |||
| F Leopardi | |||
| N Iwakoshi | |||
| A C Gibby | |||
| A J Page | |||
| E K Page | |||
| J B Jenkins | |||
| J Kwun | |||
| R A Hennigar | |||
| S J Knechtle | |||
| P2860 | cites work | Induction immunosuppression improves long-term graft and patient outcome in organ transplantation: an analysis of United Network for Organ Sharing registry data | Q33740587 |
| Preemptive CD20+ B cell depletion attenuates cardiac allograft vasculopathy in cyclosporine-treated monkeys | Q33755443 | ||
| Anti-HLA antibodies after solid organ transplantation | Q33856062 | ||
| Selective Targeting of Human Alloresponsive CD8+ Effector Memory T Cells Based on CD2 Expression | Q34149246 | ||
| Immunologic risk factors for chronic renal allograft dysfunction | Q34388849 | ||
| Effects of in vitro corticosteroids on B cell activation, proliferation, and differentiation | Q34533716 | ||
| Selective targeting of T cell subsets: focus on alefacept - a remittive therapy for psoriasis | Q34602577 | ||
| Alemtuzumab induction in renal transplantation | Q34660489 | ||
| Calcineurin inhibitor nephrotoxicity | Q34945314 | ||
| Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates | Q34991139 | ||
| Development of a diphtheria toxin based antiporcine CD3 recombinant immunotoxin | Q35436191 | ||
| Surveillance of alloantibodies after transplantation identifies the risk of chronic rejection | Q35669313 | ||
| Donor-specific antibodies and kidney transplant rejection. | Q35758938 | ||
| Antibody-mediated organ-allograft rejection | Q36263023 | ||
| The spectrum of antibody-mediated renal allograft injury: implications for treatment | Q37176570 | ||
| Differential effects of donor-specific alloantibody | Q37308415 | ||
| Four stages and lack of stable accommodation in chronic alloantibody-mediated renal allograft rejection in Cynomolgus monkeys | Q37485481 | ||
| The pathogenesis and treatment of chronic allograft nephropathy | Q37563986 | ||
| Overcoming Chronic Rejection-Can it B? | Q37621193 | ||
| The review by Kwun and Knechtle-"can it B?"-asks whether B cells are responsible for chronic rejection of transplants | Q37621195 | ||
| CCR5 blockade modulates inflammation and alloimmunity in primates | Q39439440 | ||
| First experience with the use of a recombinant CD3 immunotoxin as induction therapy in pig-to-primate xenotransplantation: the effect of T-cell depletion on outcome | Q40300114 | ||
| Flow cytometry crossmatching as a predictor of acute rejection in sensitized recipients of cadaveric renal transplants. | Q40769068 | ||
| The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by 3 cyclosporine regimens | Q41071410 | ||
| B cells help alloreactive T cells differentiate into memory T cells. | Q42409134 | ||
| Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation | Q42502255 | ||
| Investigation of lymphocyte depletion and repopulation using alemtuzumab (Campath-1H) in cynomolgus monkeys | Q43085212 | ||
| Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplant analysis using flow cytometric techniques | Q43618124 | ||
| Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure | Q43918875 | ||
| Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study. | Q44461489 | ||
| The natural history of chronic allograft nephropathy | Q44688416 | ||
| Correlation between human leukocyte antigen antibody production and serum creatinine in patients receiving sirolimus monotherapy after Campath-1H induction | Q45072989 | ||
| Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion | Q45262215 | ||
| Early and limited use of tacrolimus to avoid rejection in an alemtuzumab and sirolimus regimen for kidney transplantation: clinical results and immune monitoring. | Q46062496 | ||
| Summary of the effect of de novo HLA antibodies on chronic kidney graft failure. | Q46683381 | ||
| Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin | Q46797338 | ||
| Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free kidney transplant immunosuppression | Q46816120 | ||
| Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. | Q47206753 | ||
| Human leukocyte antigen antibodies and chronic rejection: from association to causation | Q47563762 | ||
| Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation. | Q50765005 | ||
| A fold-back single-chain diabody format enhances the bioactivity of an anti-monkey CD3 recombinant diphtheria toxin-based immunotoxin. | Q50937398 | ||
| Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties. | Q51541351 | ||
| Changes in circulating lymphocyte subpopulations following administration of the leucocyte function-associated antigen-3 (LFA-3)/IgG1 fusion protein alefacept. | Q51976501 | ||
| Effects of long-term low-dose corticosteroid therapy on humoral immunity. | Q51980437 | ||
| Genetic construction and characterization of an anti-monkey CD3 single-chain immunotoxin with a truncated diphtheria toxin. | Q51998386 | ||
| Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes. | Q52018451 | ||
| Peritubular capillaritis in renal allografts: prevalence, scoring system, reproducibility and clinicopathological correlates. | Q53033816 | ||
| 14th International HLA and Immunogenetics Workshop Prospective Chronic Rejection Project: a three-year follow-up analysis. | Q53211821 | ||
| Alloimmunity in primate heart recipients with CD154 blockade: evidence for alternative costimulation mechanisms. | Q53639153 | ||
| Relationship of donor-specific class-I anti-HLA antibodies detected by ELISA after kidney transplantation on the development of acute rejection and graft survival | Q73246916 | ||
| Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome1 | Q73276645 | ||
| Improved flow cytometric detection of HLA alloantibodies using pronase: potential implications in renal transplantation | Q73575601 | ||
| The use of positive B cell flow cytometry crossmatch in predicting rejection among renal transplant recipients | Q74613804 | ||
| Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection | Q74644326 | ||
| Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch | Q77309279 | ||
| Chronic antibody mediated rejection of renal allografts: pathological, serological and immunologic features in nonhuman primates | Q79741123 | ||
| Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN') | Q79921621 | ||
| Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss | Q80225059 | ||
| Costimulation blockade followed by a 12-week period of cyclosporine A facilitates prolonged drug-free survival of rhesus monkey kidney allografts | Q81820227 | ||
| A human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys: induction and maintenance therapy | Q84056960 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2395-2405 | |
| P577 | publication date | 2012-07-09 | |
| P1433 | published in | American Journal of Transplantation | Q4744273 |
| P1476 | title | Enhanced de novo alloantibody and antibody-mediated injury in rhesus macaques | |
| P478 | volume | 12 |
| Q36922103 | Antibody-Mediated Rejection in Sensitized Nonhuman Primates: Modeling Human Biology. |
| Q38568848 | Clinical consequences of circulating CD28-negative T cells for solid organ transplantation. |
| Q37700827 | Costimulation blockade alters germinal center responses and prevents antibody-mediated rejection |
| Q39025865 | Crosstalk Between T and B Cells in the Germinal Center After Transplantation. |
| Q92203143 | Immunization with Pneumocystis recombinant KEX1 induces robust and durable humoral responses in immunocompromised non-human primates |
| Q41296016 | Impact of irradiation and immunosuppressive agents on immune system homeostasis in rhesus macaques. |
| Q38118743 | Lymphodepletional strategies in transplantation. |
| Q33891669 | Neutralizing BAFF/APRIL with atacicept prevents early DSA formation and AMR development in T cell depletion induced nonhuman primate AMR model. |
| Q38445344 | Novel insights into anti-CD40/CD154 immunotherapy in transplant tolerance |
| Q37248703 | Post-transplant lymphoproliferative disorder associated with immunosuppressive therapy for renal transplantation in rhesus macaques (Macaca mulatta). |
| Q37362699 | Post-transplant repopulation of naïve and memory T cells in blood and lymphoid tissue after alemtuzumab-mediated depletion in heart-transplanted cynomolgus monkeys |
| Q38660463 | Preclinical modeling of hematopoietic stem cell transplantation - advantages and limitations |
| Q37122367 | Primate models in organ transplantation |
| Q38187176 | Recollective homeostasis and the immune consequences of peritransplant depletional induction therapy |
| Q91554792 | Transplant research in nonhuman primates to evaluate clinically relevant immune strategies in organ transplantation |
Search more.